HomeProductsBioactive CompoundsDNA Damage & RepairTopoisomeraseCAS 89459-25-6
Chemical structure of CAS 89459-25-6

N-(2-(Dimethylamino)ethyl)acridine-4-carboxamide

In Stock•Starting at $94 for 10 mg•Purity ≥ 95%
CAS No.89459-25-6
MDL No.MFCD00869683
MFC18H19N3O
MW293.40
InChI KeyXBGNERSKEKDZDS-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
10 mg95.0%$94In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.89459-25-6
Product NameN-(2-(Dimethylamino)ethyl)acridine-4-carboxamide
Heavy Atom Count22Rotatable Bond Count4
Atom Stereo Count0Bond Stereo Count0
HBA3HBD1
TPSA45.230 ŲCharge0
Exact Mass293.15281Complexity826.79
pKa5.875XLogP2.679

Related Articles

Studies related to this compound and its mechanism of action

Use of positron emission tomography in pharmacokinetic studies to investigate therapeutic advantage in a phase I study of 120-hour intravenous infusion XR5000.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 21, Issue 2 • 2003
PMID: 12525511DOI: 10.1200/JCO.2003.02.008

Kinetic studies of the binding of acridinecarboxamide topoisomerase poisons to DNA: implications for mode of binding of ligands with uncharged chromophores.

Journal of medicinal chemistry • Vol. 45, Issue 4 • 2002
PMID: 11831901DOI: 10.1021/jm000473g

Inter-strain variability in aldehyde oxidase activity in the mouse.

Comparative biochemistry and physiology. Toxicology & pharmacology : CBP • Vol. 132, Issue 3 • 2002
PMID: 12161167DOI: 10.1016/s1532-0456(02)00057-1

Pharmacokinetic evaluation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in patients by positron emission tomography.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • Vol. 19, Issue 5 • 2001
PMID: 11230487DOI: 10.1200/JCO.2001.19.5.1421

Documentation

Similar Products